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acute pancreatitis (n=3). At study entry, 14 (74%) patients were
in the ICU (median Simplified Acute Physiology Score II 45, range
31-65), 19 (100%) received antibacterial therapy and 17 (89%) were
colonized with Candida (C. albicans in 69%; CCI ≥0.4 in 1/17 case,
5%). Median duration of CSP Px was 16 days (range 4-46). During
CSP Px, 17 (89%) patients remained colonized (C. albicans in 68%),
but 0/17 developed a CCI ≥0.4. CSP was successful for prevention
of IC in 18 (95%) patients. Among 5 deaths, none was attributed
to IC. No severe CSP-related SAE requiring discontinuation of Px
occurred.
Discussion: The results of this pilot study suggest that caspofungin
is efficacious and safe for prophylaxis of intra-abdominal candidia-
sis in high-risk surgical patients.
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Objectives: The aim of this study was to evaluate the incidence of
microbial pathogens isolated from cultures of venous catheter tips
(VCT) and determine their susceptibility patterns to antimicrobial
agents from patients hospitalized in the intensive care unit (ICU).
Methods: During a four year period (2003-2007) 925 VCT were cul-
tured from patients hospitalized in the ICU of our hospital. Patients
between 18-60 years aged and were hospitalized for more than 48
hours. Specimens were cultured and evaluated according to the
semi-quantitative method (MAKI' S) for aerobic microorganisms and
fungi. Antibiotic susceptibility testing was performed by the agar
disk diffusion method according to CLSI guidelines.
Results: From 925 VCT cultures 158 (17%) were positive. Of them
23% grew Acinetobacter baumanii, 22% Pseudomonas aeruginosa,
26% Enterobacteriaceae, 6% Enterococcus spp., 3% Staphylococcus
aureus, 16% Staphylococcus coagulase-negative and 3% Candida
spp. 74% of A. baumanii and Ps. aeruginosa strains were resistant
to Carbapanems, 69% to Gentamycin and 81% to Amikacin.
Twenty-six percent of Enterobacteriaceae strains were resistant to
Carbapenems, 24% to Gentamycin and 48% to Amikacin. From S. au-
reus and Staphylococcus coagulase-negative isolated strains 60%
and 66% respectively were resistant to Methicilin. 22% of Entero-
coccus spp. were resistant to Vancomycin and Teicoplanin (van A).
Conclusions: A. baumanii and Ps. aeruginosa were the most
common isolated pathogens followed by Staphylococci coagulase-
negative. An elevated percentage of multiresistant strains was ob-
served. The knowledge of the resident microbial flora and their
antimicrobial susceptibility profiles is necessary in order to formu-
late a rational policy in patients with catheter devices.
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Background: Enterococci may not be the main pathogens associ-
ated with Intensive Care Unit (ICU) patients infections but their
increasing resistance rates to many commonly administrated an-
tibiotics often leads to the need of using a combination of an-
timicrobial agents when dealing with these infections. Even though
aminoglycosides used alone have very low efficiency against these
microorganisms, their combination with an antibiotic that targets
bacterial cell wall has proved to be successful. Testing for high
level aminoglycoside resistance (HLAR) is a laboratory means of
evaluating the efficiency of such a combination.
Objectives: To assess antimicrobial susceptibility rates and HLAR
of Enterococcus strains isolated from ICU patients during one year
period of time.
Methods: Between 01-01-2007 and 31-12-2007, 50 Enterococcus
strains were isolated from different ICU patients' samples (mainly
bronchial aspirates, urine, blood and wounds). Identification of
bacteria was made by standard laboratory proceedings and suscep-
tibility testing to antimicrobial agents was performed with the disk
diffusion test (Kirby-Bauer method) along with the miniAPI system.
HLAR test was performed with the disk diffusion test according to
the CLSI guidelines with the use of 120 microgram Gentamicin and
300 microgram Streptomycin disks.
Results: Enterococcus faecium was the most frequent enterococ-
cal isolate (40%), followed by Ent. faecalis (32%), Ent. casseliflavus
(12%), Ent. gallinarum (12%) and Ent. durans (4%). All strains
were susceptible to vancomycin and teicoplanin while susceptibil-
ity rates for quinupristin-dalfopristin were for Ent. faecium 40%,
Ent. faecalis 0%, Ent. casseliflavus 0%, Ent. gallinarum 66.6% and
Ent. durans 0%. HLAR is shown in the following table.
Gentamicin 120µg Streptomycin 300µg
(R %) (R %)
Ent. faecium 60 90
Ent. faecalis 50 50
Ent. casseliflavus 33.3 33.3
Ent. gallinarum 0 33.3
Ent. durans 100 100
Conclusions: Glycopeptides remain highly efficient while strep-
togramins showed lower efficiency. Enterococci species isolated
from ICU patients had high HLAR rates especially in the case of
Ent. faecium, Ent. faecalis and Ent. durans. Since high level resis-
tance to aminoglycosides means that these antibiotics will not be
synergistic with cell-wall-active agents, testing for HLAR is impor-
tant for the proper therapeutical approach of these patients.
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Background: Gram-negative bacteria are the main pathogens asso-
ciated with Intensive Care Unit (ICU) patients infections and their
increasing resistance rates to multiple antimicrobial agents con-
tribute to high morbidity and mortality rates.
Objectives: To assess susceptibility rates to carbapenems and
aminoglycosides of the most frequently isolated Gram-negative
bacteria from ICU clinical specimens.
Methods: During one year period of time (1/1/2007 till
31/12/2007) 409 Gram-negative bacterial strains were recovered
from different samples obtained from ICU patients (including
bronchial aspirates, urine, central venous catheters, blood and
